CURRENT ISSUE PREVIOUS ISSUES COMMENTARY ABOUT US CONTACT US
 
mbs

VOLUME 8, ISSUE 3 - Fall 2014

The Global Climate of Drug Abuse Part 2

In our continuing journey around the world, with the theme of “The Global Climate of Drug Abuse Part II,” we head “Down Under” to hear from several of our colleagues who have shared their global perspectives in the effort to prevent the ravages of substance abuse on world society.

First up is an original paper titled, HIV and HCV Transmission Among Intravenous Drug Users by Dr Ross Colquhoun, Dalgarno Institute and Gary Christian, Drug Free Australia. The paper examines the evidence for harm reduction policies on HIV and HCV transmission, evaluating the benefit to drug users and the community.

The next article by Josephine Baxter, Executive Officer of Drug Free Australia, Changing the Market Culture for Methamphetamines: Models of Demand Reduction – An Australian Perspective, will provide working examples in three countries as to what can be done to achieve greater prevention in methamphetamine use and harm, with demand reduction and early intervention models being described.

Our commentary contribution was shared with the Journal from the esteemed World Federation Against Drugs (WFAD).  In this reprinted piece, Comment on Global Commission on Drug Policy’s report; Taking Control: Pathways to Drug Policies that Work, WFAD provides a counter perspective to the report of the self-appointed Commission that seeks to weaken international drug laws.

IN THIS ISSUE

HIV and HCV Transmission Among Intravenous Drug Users

Changing Market Culture for Methamphetamines

COMMENTARY

Comment on Global Commission on Drug Policy's report; Taking Control: Pathways to Drug Policies that Work


UPDATES
  Research
  International Drug Policy
  In The News


 

The Journal of Global Drug Policy and Practice, a joint effort of the Institute on Global Drug Policy and the International Scientific and Medical Forum on Drug Abuse, is an international, open access, peer-reviewed, online journal with the goal of bridging the information gap on drug policy issues between the medical/scientific community, policymakers and the concerned lay public.

Edited by Eric A. Voth, MD, FACP and David A. Gross, MD, DFAPA, our intended readership includes clinicians, clinical researchers, policymakers, prevention specialists and the interested public.

HIV and HCV Transmission Among Intravenous Drug Users

Dr Ross Colquhoun, Dalgarno Institute, Gary Christian, Drug Free Australia

Changing Market Culture for Methamphetamines

Josephine Baxter, Executive Officer, Drug Free Australia

RSS Privacy Policy Terms of Use Contact Us Information for Authors